Antiviral activities of type I interferons to SARS-CoV-2 infection
- 29 April 2020
- journal article
- research article
- Published by Elsevier BV in Antiviral Research
- Vol. 179, 104811
- https://doi.org/10.1016/j.antiviral.2020.104811
Abstract
No abstract availableKeywords
Funding Information
- NIH (AI060549)
- Public Health Service (RO1AI093445, RO1AI129198)
- UTMB (P84373)
- Public Health Service (5UC7AI094660)
This publication has 30 references indexed in Scilit:
- Interferon-stimulated genes and their antiviral effector functionsCurrent Opinion in Virology, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 proteinNature Structural & Molecular Biology, 2009
- Molecular Determinants for Subcellular Localization of the Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame 3b ProteinJournal of Virology, 2009
- Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3·TANK·TBK1/IKKϵ ComplexOnline Journal of Public Health Informatics, 2009
- SARS coronavirus accessory proteinsVirus Research, 2008
- Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome CoronavirusOnline Journal of Public Health Informatics, 2007
- Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi MembraneJournal of Virology, 2007
- Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon AntagonistsJournal of Virology, 2007
- Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradationProceedings of the National Academy of Sciences of the United States of America, 2006